Deltex Medical Share Price (DEMG)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Deltex Medical Group	LSE:DEMG	London	Ordinary Share	GB0059337583	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+0.00p	+0.00%	4.00p	3.75p	4.25p	4.25p	4.00p	4.00p	353,832	13:28:13

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Health Care Equipment & Services	6.4	-3.6	-1.6	-	11.87

Related Shares
Smith & Nephew (SN.), Convatec (CTEC), Microemissive Displays (MED), Aortech (AOR)

Deltex Medical (DEMG) Latest News

Deltex Medical News

Date	Time	Source	Headline
13/6/2017	09:30	UKREG	Deltex Medical Group PLC Director/PDMR Shareholding
09/6/2017	13:25	UKREG	Deltex Medical Group PLC Result of AGM
09/6/2017	09:11	ALNC	Deltex Medical Says UK Remains Challenging As It Aims To Break Even
09/6/2017	07:10	ALNCF	Alliance News Flash Headline
09/6/2017	07:00	UKREG	Deltex Medical Group PLC AGM Statement
09/6/2017	07:00	RNSNON	Deltex Medical Group PLC Excellent Results from New Trial
31/5/2017	09:26	ALNC	Deltex Gets New Patent For Combo Blood Flow, Blood Pressure Monitor
31/5/2017	07:01	RNSNON	Deltex Medical Group PLC Patent Grant
26/5/2017	10:24	ALNC	Deltex Medical Makes 1st Sale Of Monitoring System For Veterinary Use
26/5/2017	07:01	RNSNON	Deltex Medical Group PLC Launch of ODMV+ system for veterinary anaesthesia

More Deltex Medical News

Deltex Medical Takeover Rumours

Deltex Medical (DEMG) Share Charts

1 Year Deltex Medical Chart

1 Month Deltex Medical Chart

Intraday Deltex Medical Chart

Deltex Medical (DEMG) Discussions and Chat

Deltex Medical Forums and Chat

Date	Time	Title	Posts
24/6/2017	11:26	Deltex Medical - a British success story!	8,861
19/5/2017	14:51	Deltex Medical - winner or doomed to fail?	151
14/7/2014	11:16	Deltex Medical-Optimal Growth Stock	10,005
22/3/2012	09:04	Deltex Medical - Past, Present and Future	-
07/12/2011	11:57	Deltex Medical - More key endorsements	-

Add a New Thread

Deltex Medical (DEMG) Most Recent Trades

No Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type

View all Deltex Medical trades in real-time

Deltex Medical (DEMG) Top Chat Posts

Date	Subject
25/6/2017 09:20	Deltex Medical Daily Update: Deltex Medical Group is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker DEMG. The last closing price for Deltex Medical was 4p. Deltex Medical Group has a 4 week average price of 3.63p and a 12 week average price of 3.63p. The 1 year high share price is 5.75p while the 1 year low share price is currently 3.63p. There are currently 296,819,511 shares in issue and the average daily traded volume is 131,570 shares. The market capitalisation of Deltex Medical Group is £11,872,780.44. Read Full Thread Reply
21/6/2017 20:54	buywell3: Well atleast 2 trades today anyway : one trade for £917 worth and another for £529 worth, but I take your point a trade is a trade no matter how tiny. Deltex Medical Group (LSE:DEMG) Share Price Alert 3.7500 Today's low: 4.0000 Sell DEMG 4.2500 Today's high: 4.0850 Buy DEMG Last trade:4.0000 Change: - (-%) Volume:35,864 Delayed price:13:35:11 Summary News Discussion Chart... Analysis... Latest trades Time Price Volume Value 13:35:11 4 22,913 917 08:02:24 4.085 12,951 529 Read Full Thread Follow Reply
10/2/2017 17:26	yump: Well the net result of the buying and selling at historic lows has been nothing for the last few days, so for every seller who has got bored, a buyer thinks its near the bottom. At the moment it seems to be a firmish bottom, rather than a wobbly one, so the interpretation could be mildly positive. At some point, if there is no more bad news for a share, the continual drops stop. Then it takes a while for the buying to outweigh the selling. Back in August/September there was more positive news on US, which appears to have caused a small spike, but the effect of that and the UK on the figures was unknown. Now things are a little more certain and the actual business problems caused by the UK falling, look likely to stabilise. Its possible the previous bad news and problems are all in the price at last and now its just a question of waiting for the results to show revenue starting to grow. I hope so as got quite a few around 4p now, on the basis that I think any tangible improvement will cause a rapid share price rise which will not come back down again. Fingers and other stuff crossed ! Read Full Thread Follow Reply
06/2/2017 11:35	gbenson1: A rise in the share price would be nice, break even will come sooner rather than later, we need to be pushing PR and sales more in the US to get on the radar, someone is building a stake? Read Full Thread Follow Reply
20/1/2017 23:38	february 30th: It's not just the USA, it's the ROW. The relatively strong Euro must be helpful, while it lasts. As for the fall in the share price post update, I don't find it entirely convincing. The update was everything we expected, plus the 30 US accounts had been achieved, albeit quite a few months after Labor Day! Prior to the announcement there might have been some fear that the accounts were drying up, which has been allayed. If a couple more accounts could be announced by the end of February, that would suggest a minor-breakthrough. Read Full Thread Follow Reply
18/1/2017 10:29	zho: Equity Development: FY16 group revenues reached £6.3m in FY16 vs £6.2m (ex-research barter sales of £0.2m) marginally lower than the £6.4m total in FY15. KPI probe sales reached £5.4m (£5.2m) with sustained momentum from US revenues, up 40% to £1.9m in FY16, counterbalancing UK weakness. Looking ahead, with two new platform accounts added post year end, DEMG has reached a milestone of 30 US platform accounts, which could see higher margin US sales outperform other geographies for the first time in 2017. By contrast, as flagged, UK sales declined 26% vs FY15 to £1.9m as a result of attrition and the lack of advanced haemodynamic management within the NHS. Meanwhile, revenues from international sales grew 20% to £1.7m led by France, Scandinavia, Peru and Korea, illustrating the potential in these most ODM-receptive markets. The overall picture is of higher margin US sales on track to lead revenues from FY17. This, coupled with cost-cutting initiatives including in-house probe assembly leading to c £30,000 net savings/month, suggest margin expansion towards historical 70% levels is in sight. DEMG‘s end 2016 cash position of £0.6m, net of an £0.5m fund raise in July, provides short term funding. Pressure on sales has led to downgrades and a volatile 12-month share price performance. The current EV sales multiple of 2x implies expectations of further downgrades, although the current run rate in the US suggests DEMG could have reversed the overall financial downward trend. We will reinstate forecasts at the FY16 results due to be reported in the week of 20 March. Read Full Thread Follow Reply
11/10/2016 12:23	arf dysg: Any guesses as to why Lidco's share price and Deltex's share price have gone up today? I notice that Lidco, in its half-year report, says that it is the "clear market leader in the home market". Surely that wouldn't be a dig at anyone? Read Full Thread Follow Reply
10/10/2016 10:53	yump: I'm sure there's a lot of folk here who didn't realise that the share price had dropped from its peaks, so that's really helpful to know. Its just a shame that some super-clever folk couldn't have drawn in any lines down to 5p when the share price was 30p. Its probably worth posting on all the shares in the market with some lines showing what could happen on the downside. Then at least it will look like a prediction, rather than a statement of the bleeding obvious. Read Full Thread Follow Reply
12/7/2016 14:16	djgrantb: This share price defies logic, almost 190k bought and 48k sold, share price down, the MMs are having a laugh.... Strong buys the other day, the share price rises before any trades go through and doesn't move a jot all day.... Read Full Thread Follow Reply
29/5/2014 09:01	buywell2: The DEMG share price is not funny or laughing matter for many I would hazard Read Full Thread Follow Reply
01/5/2014 20:34	doglover2003: -- > Feb 30th DEMG management would certainly defend the company very determinedly and would not be recommending any offer to shareholders unless of several multiples of turnover and payable 100 per cent in cash. Therefore, I think you would find that DEMG management would make the Optimise Trial a very important issue for LIDCO shareholders. Any offer by LIDCO would probably produce a re-rating of DEMG and a hammering for LIDCO share price which would make the whole takeover unworkable. Even today LIDCO failed to produce evidence in support of their technology without mentioning DEMG in the same breadth as part of the trial. As for the DEMG share price, the substantial fall in the share price took place on very modest volumes. Conversely, it would not take mega volume to move the price in the opposite direction. DL Read Full Thread Follow Reply

Deltex Medical share price data is direct from the London Stock Exchange

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:43 V: D:20170625 20:38:59